Skip to main content
SpringerLink
Log in

NECC ceases operations following fungal meningitis outbreak

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Food and Drug Administration.New England Compounding Center (NECC) Potentially Contaminated Medication: Fungal Meningitis Outbreak. Internet Document: [2 pages], 8 Oct 2012. Available from: URL: http://www.fda.gov

  2. New England Compounding Pharmacy Inc.New England Compounding Center Issues Voluntary Nationwide Recall of All Products. Media Release: 6 Oct 2012. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NECC ceases operations following fungal meningitis outbreak. React. Wkly. 1423, 1 (2012). https://doi.org/10.2165/00128415-201214230-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214230-00001

Keywords

Search

Navigation